Ashe J H, Yarosh C A
Neuropharmacology. 1984 Nov;23(11):1321-9. doi: 10.1016/0028-3908(84)90053-4.
Two cholinergic antagonists, gallamine and pirenzepine, agents that have been shown to bind selectively to different subpopulations of the muscarinic receptor, were found to antagonize selectively and differentially the amplitudes of the slow-inhibitory and slow-excitatory postsynaptic potentials in the superior cervical ganglion of the rabbit. Incubation of ganglia with gallamine resulted in a concentration-dependent suppression of the slow-inhibitory postsynaptic potential. The pharmacological action of gallamine was highly specific. At concentrations which reduced the amplitude of the slow-inhibitory postsynaptic potential by as much as 70-90%, there was no reduction of the amplitudes of the muscarinic slow-excitatory postsynaptic potential, the nicotinic fast-excitatory postsynaptic potential, noncholinergic slow-slow-excitatory postsynaptic potential, or post-stimulus hyperpolarizing afterpotentials. The amplitude of the slow-excitatory postsynaptic potential was actually facilitated in the presence of gallamine, presumably as a result of suppression of the overlapping slow-inhibitory postsynaptic potential. In contrast to the action of gallamine, pirenzepine produced a selective suppression of the amplitude of the slow-excitatory postsynaptic potential. Pirenzepine had very little influence on the amplitude of the slow-inhibitory postsynaptic potential at concentrations sufficient to reduce the amplitude of the slow-excitatory postsynaptic potential by as much as 50%, and had no effect on the amplitudes of the nicotinic fast-excitatory postsynaptic potential or noncholinergic slow-slow-excitatory postsynaptic potential. The evidence presented suggests that multiple muscarinic recognition sites, previously identified by studies of the affinities of pharmacological agents for the muscarinic receptor, may actually be involved in synaptic transmission and functionally coupled to cellular effector mechanisms.
两种胆碱能拮抗剂,加拉明和哌仑西平,已被证明能选择性地结合毒蕈碱受体的不同亚群,它们被发现能选择性地、差异性地拮抗家兔颈上神经节中慢抑制性和慢兴奋性突触后电位的幅度。用加拉明孵育神经节会导致慢抑制性突触后电位呈浓度依赖性抑制。加拉明的药理作用具有高度特异性。在能使慢抑制性突触后电位幅度降低多达70 - 90%的浓度下,毒蕈碱慢兴奋性突触后电位、烟碱快速兴奋性突触后电位、非胆碱能慢 - 慢兴奋性突触后电位或刺激后超极化后电位的幅度均未降低。实际上,在加拉明存在的情况下,慢兴奋性突触后电位的幅度有所增强,推测这是由于重叠的慢抑制性突触后电位受到抑制的结果。与加拉明的作用相反,哌仑西平能选择性地抑制慢兴奋性突触后电位的幅度。在足以使慢兴奋性突触后电位幅度降低多达50%的浓度下,哌仑西平对慢抑制性突触后电位的幅度影响很小,对烟碱快速兴奋性突触后电位或非胆碱能慢 - 慢兴奋性突触后电位的幅度也没有影响。所提供的证据表明,先前通过研究药物对毒蕈碱受体的亲和力而确定的多个毒蕈碱识别位点,可能实际上参与了突触传递,并在功能上与细胞效应机制相耦合。